Patents for A61P 35 - Antineoplastic agents (221,099)
10/2012
10/24/2012CN102743516A Traditional Chinese medicine composition for treating flesh goiter and preparation method thereof
10/24/2012CN102743488A Chinese medicament for treating liver cancer
10/24/2012CN102743469A New use of Hedyotis hedyotidea (DC.) Merr. for treating diseases
10/24/2012CN102743436A Application of effective part of salvianolic acid in preparing preparation for preventing and treating mouth and throat diseases
10/24/2012CN102743423A Traditional Chinese medicine preparation for treating liver diseases and preparation method thereof
10/24/2012CN102743416A Preparation method of nano-propolis solution
10/24/2012CN102743393A Medicinal composition containing abiraterone acetate and preparation technology thereof
10/24/2012CN102743376A Costustoot pharmaceutical composition and medicinal application
10/24/2012CN102743343A Decitabine composition, preparation method thereof, application thereof in medicinal lyophilized preparation, medicinal lyophilized preparation product, and preparation method of medicinal lyophilized preparation product
10/24/2012CN102743337A Nano-particulate medicinal composition and preparation method thereof
10/24/2012CN102743336A Preparation method and application of curcumin chitosan-stearic acid graft micelle
10/24/2012CN102743331A Disinfection preparation containing levorotatory folinic acid sodium
10/24/2012CN102743328A Intrauterine sustained control release drug delivery system adopting biodegradation material, and preparation method thereof
10/24/2012CN102743327A Nano-scale artificial oil body for targeted drug delivery system detection and treatment
10/24/2012CN102743326A Nano-scale artificial oil body for targeted drug delivery system detection and treatment
10/24/2012CN102743325A Nano-scale artificial oil body for targeted drug delivery system detection and treatment
10/24/2012CN102743324A Nano-scale artificial oil body for targeted drug delivery system detection and treatment
10/24/2012CN102311476B Toonapubesin C and preparation method as well as application thereof
10/24/2012CN102302742B Traditional Chinese medicine composition for treating cardiac cancer and esophageal cancer
10/24/2012CN102302503B Preparation method for daunorubicin and 5-bromotetrandrine co-carried magnetic ferrosoferric oxide nanoparticles
10/24/2012CN102266308B Method for preparing odor masking sustained-release garlicin composite micro-capsules
10/24/2012CN102145181B siRNA for inhibiting tumor growth and oligomeric nucleic acid combination and application of siRNA
10/24/2012CN102026669B Application of conjugates for the treatment of mesothelioma
10/24/2012CN102008732B Folate conjugated antibody medicament and preparation method and application thereof
10/24/2012CN102000120B Method for extracting medicinal active substance from suillus luteus and application
10/24/2012CN101991537B Compound fluorouracil liposome oral liquid and preparation method thereof
10/24/2012CN101899082B Triterpenoid saponin compound, application and preparation method
10/24/2012CN101822711B Preparation method of traditional Chinese medicine perfusate and application
10/24/2012CN101797328B Production process of Zhenqi capsule and test method thereof
10/24/2012CN101766690B Multipurpose utilization method for improving the value of schisandra chinensis medicinal material
10/24/2012CN101585861B N-glycosyl naphthocarbazole compound and synthesis method and application thereof
10/24/2012CN101422424B Mycophenolic acid medicine implantation agent and preparation method and use thereof
10/24/2012CN101322689B Preparation of docetaxel long-circulating liposome and freeze-dried powder injection thereof
10/24/2012CN101321861B Method for generating dendritic cells employing decreased temperature
10/23/2012US8293902 Quinazoline compounds
10/23/2012US8293901 MAPK/ERK kinase inhibitors
10/23/2012US8293897 Compounds comprising a spiro-ring and methods of use
10/23/2012US8293896 Chemokine receptor antagonists and use thereof
10/23/2012US8293763 8-anilinoimidazopyridines and their use as anti-cancer and/or anti-inflammatory agents
10/23/2012US8293703 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
10/23/2012US8293513 Histone deacetylase inhibitors
10/23/2012US8293268 Local administration of gallium compositions to treat pain
10/23/2012CA2672903C Heterocyclic compounds and their use in treating inflammation, angiogenesis and cancer
10/23/2012CA2523178C Materials and methods to potentiate cancer treatment
10/23/2012CA2418802C Polypeptide regulating phosphate metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same
10/23/2012CA2418411C Inhibitory, monoclonal antibody against blood clotting factor vii-activating protease
10/23/2012CA2384978C Udp-n-acetylglucosamine: galactose-.beta.1,3-n-acetylgalactosamine-.alpha.-r/(glcnac to galnac) .beta.1,6-n-acetylglucosaminyltransferase, c2gnt3
10/23/2012CA2361009C Her-2/neu fusion proteins
10/23/2012CA2284829C Immunotherapy of b-cell malignancies using anti-cd22 antibodies
10/18/2012WO2012142615A2 Auranofin and auranofin analogs useful to treat proliferative disease and disorders
10/18/2012WO2012142604A2 Targeting deregulated wnt signaling in cancer using stabilized alpha-helices of bcl-9
10/18/2012WO2012142575A2 Monomeric trioxane amide sulfur compounds
10/18/2012WO2012142526A1 Use of tumor fas expression to determine response to anti-cancer therapy
10/18/2012WO2012142513A1 Substituted benzene compounds
10/18/2012WO2012142504A1 Aryl-or heteroaryl-substituted benzene compounds
10/18/2012WO2012142391A1 Anti- il-1r1 inhibitors for use in cancer
10/18/2012WO2012142330A1 Micro rnas as diagnostic biomarkers and therapeutics for ovarian cancer and metastatic tumors that disseminate within the peritoneal cavity
10/18/2012WO2012142325A1 Combination of motesanib, a taxane and a platinum-containing anti-cancer drug for use in the treatment of non-small cell lung cancer in a population subset
10/18/2012WO2012142245A2 Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use
10/18/2012WO2012142117A1 Solid state forms of cabazitaxel and processes for preparation thereof
10/18/2012WO2012142083A2 C1q/tnf-related protein 12 and compositions and methods of using same
10/18/2012WO2012142029A2 Serms for the treatment of estrogen receptor-mediated disorders
10/18/2012WO2012141604A1 Asymmetrically substituted anthrapyridazone derivatives as cytostatics
10/18/2012WO2012141504A2 Brg-1-derived bromodomain, and use thereof
10/18/2012WO2012141201A1 Peptide for cancer immunotherapy and method using same
10/18/2012WO2012140852A1 Composition increasing the activity of dehydrogenase, and composition for liver disease
10/18/2012WO2012140680A1 Nanotori of semiconductor material for use in diagnostics and in the anti-tumor therapy and process for the production thereof
10/18/2012WO2012140636A1 A probiotic formulation
10/18/2012WO2012140436A1 Dosage regimen for sapacitabine and decitabine in combination for treating acute myeloid leukemia
10/18/2012WO2012140419A1 Chromenone compounds as pi 3 -kinase inhibitors for the treatment of cancer
10/18/2012WO2012140300A1 Compounds and compositions for treating multiple myeloma
10/18/2012WO2012140234A1 Modulation of mirna in diseases with aberrant angiogenesis
10/18/2012WO2012140114A1 Tri- and tetracyclic pyrazolo[3,4-b]pyridine compounds as antineoplastic agent
10/18/2012WO2012140032A1 Avian metapneumovirus in oncolysis
10/18/2012WO2012140020A1 Novel piperidinyl monocarboxylic acids as s1p1 receptor agonists
10/18/2012WO2012139993A1 1,3 oxazines as bace1 and/or bace2 inhibitors
10/18/2012WO2012139930A1 Pyrazolyl-pyrimidine derivatives as kinase inhibitors
10/18/2012WO2012139628A1 Coding polypurine hairpins for the treatment of cancer
10/18/2012WO2012139522A1 Dehydrocostus lactone derivative, pharmaceutical compositions thereof, preparation method therefor, and uses thereof
10/18/2012WO2012139507A1 Application of bisphenol fluorene and derivative thereof in preparing medicament for prophylaxis and treatment of cancer
10/18/2012WO2012139499A1 Urea compounds as well as preparation methods, intermediates and uses thereof
10/18/2012WO2012139487A1 Pegylated derivatives of camptothecin compounds
10/18/2012WO2012139469A1 Delivery system and preparation of low-interference rna drug
10/18/2012WO2012139314A1 Chinese herbal medicinal composition for treating cancer
10/18/2012WO2012115402A3 Crystalline form of docetaxel and process for preparation thereof
10/18/2012WO2012106702A3 Treatment of leukemia
10/18/2012WO2012103163A3 Compositions and methods for treating cancer while preventing or reducing cardiotoxicity and/or cardiomyopathy
10/18/2012WO2012103059A3 Bcl-2/bcl-xl inhibitors and therapeutic methods using the same
10/18/2012US20120266264 Monoclonal antibodies against gonadotropin-releasing hormone receptor
10/18/2012US20120266262 Methods and compositions relating to zpa polypeptides
10/18/2012US20120265001 Composite magnetic nanoparticle drug delivery system
10/18/2012US20120264999 4 (pyrrolopyridinyl)pyrimidin-2-ylamine derivatives
10/18/2012US20120264966 Sulfur-containing phospholipid derivatives
10/18/2012US20120264823 Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use
10/18/2012US20120264820 Synthetic Flavonoids and Pharmaceutical Compositions and Therapeutic Methods of Treatment of HIV infection and other pathologies
10/18/2012US20120264819 Therapeutic Uses of Urolithins
10/18/2012US20120264817 Solubilized formulation of docetaxel without tween 80
10/18/2012US20120264812 Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1
10/18/2012US20120264811 Elongator Proteins and Use Thereof as DNA Demethylases
10/18/2012US20120264807 Method for introducing sirna into cells by photochemical internalisation